Ionis Pharmaceuticals, Inc. (IONS)
Market Closed
3 Jun, 20:00
$
73. 82
+0.85
+1.16%
$
12.78B Market Cap
- P/E Ratio
- Div Yield
1,267,055 Volume
-3.43 Eps
$ 72.97
Previous Close 
Want to track IONS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ionis Pharmaceuticals, Inc. (IONS) Statistics
Valuation metrics
Market Cap 12.78B
Enterprise value 12.29B
Trailing P/E (ttm) -31.46
Forward P/E -121.81
PEG ratio -0.28
Price/Sales (ttm) 13.09
Price/Book (mrq) 24.97
Enterprise Value/Revenue 13.02
Enterprise Value/EBITDA -33.28
Overview
Shares outstanding 163.3M
Float 163.91M
Shares short 14.33M
% Held by insiders 0.01%
% Held by institutions 1.06%
Average volume (10 days) 1.5M
Average volume (90 days) 1.98M
Price summary
52-Week low 33.95
52-Week high 86.74
Beta 0.4
50-Day moving average 76.73
200-Day moving average 68.43
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.4%
Operating margin -1.05%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.71%
Income Statement
Revenue (ttm) 943.71M
Revenue per share (ttm) 5.9
Quarterly revenue growth (yoy) -0.1%
Gross profit (ttm) 12.18M
EBITDA -369.24M
Net income to common (ttm) -381.39M
Diluted EPS (ttm) -2.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.68B
Total cash per share (mrq) 16.23
Total debt (mrq) 2.62B
Total Debt/Equity (mrq) 534.84
Current ratio (mrq) 3.83%
Book value per share (mrq) 3
Cash Flow
Cash flow statement -268.58M
Levered free cash flow (LFCF) -154.72M
